Sign In
to Vote &
Create Storyboards.
 

Medical News

Location American Medical News for 8 October 2016
Vegan Mom Who Fed 11-Month-Old Baby Nuts And Berries Charged For Child Endangerment A mother was charged of child endangerment for feeding her 11-month-old son only nuts and berries. The child suffered from malnutrition, developmental delays and rashes.
Read More
1
0
Damian Marley, Entrepreneur: Bob Marley's Youngest Son Converting A Former California Prison Into A Pot Farm Damian Marley bought an old prison in the state of California with the aim of turning it into a facility for growing medical cannabis. If the state's Proposition 64 passes, the company will also be able to sell marijuana...
Read More
0
0
'Executioner' Protein Responsible For Brain Cell Death In Strokes, Alzheimer's Disease A new study discovered the protein responsible for cell death in almost all cases of cell injury. The mechanisms of the macrophage migration inhibitory factor in contact with the mitochondrial apoptosis-inducing factor p...
Read More
0
0
Mylan To Pay $465 Million Over EpiPen Medicaid Rebate Classification Mylan has agreed to pay $465 million after lawmakers and health officials said it wrongly classified EpiPen as a generic product. The classification allowed the pharmaceutical company to pay lower rebates for Medicaid pr...
Read More
0
0
(European Society for Medical Oncology) The addition of the CDK4/6 inhibitor ribociclib to letrozole therapy significantly improves progression-free survival in postmenopausal women with hormone receptor-positive advance...
Read More
0
0
(European Society for Medical Oncology) Immunotherapy has shown promising results in first and second line treatment of metastatic bladder cancer in two phase II trials presented at the ESMO 2016 Congress in Copenhagen.
Read More
0
0
(European Society for Medical Oncology) Fulvestrant significantly increases progression-free survival in women with hormone-receptor-positive advanced breast cancer, particularly those with less aggressive lower-volume d...
Read More
0
0
(European Society for Medical Oncology) Ipilimumab as adjuvant therapy significantly improves overall survival in patients with high risk stage III melanoma, according to the EORTC 18071 phase III trial results presented...
Read More
0
0
(European Society for Medical Oncology) The PARP inhibitor niraparib significantly improves the outcome of platinum-sensitive recurrent ovarian cancer, according to full data from the ENGOT-OV16/NOVA trial presented for ...
Read More
0
0
(European Society for Medical Oncology) The first-in-human dose escalation study of the pan-FGFR (fibroblast growth factor receptor) inhibitor BAY 1163877 in patients with treatment-refractory locally advanced or metasta...
Read More
0
0

{TITLE}

{PUBLISHER} - {PUBLISHED_DATE}
{TITLE} {CONTENT}
Read More
{VIEWS}
0


Storyboard
Print
{VIEWS}
0
0




Share this Article

Location



Create Storyboard